The report highlights Blueprint Medicines' commitment to sustainability and good corporate citizenship, outlining their progress and initiatives in areas including patient access, community engagement, research and development, employee culture, environmental sustainability, governance and ethics, and diversity, equity, and inclusion. The report details specific metrics and data for the 2021 calendar year. It highlights Blueprint Medicines' mission to develop innovative therapies for people with cancer and blood disorders, its commitment to patient support, and its efforts to create a diverse and inclusive workplace. The report also emphasizes the company's dedication to environmental sustainability, including efforts to reduce energy consumption and waste.
Go back to company
Blueprint Medicines Corporation 2021 Corporate Responsibility Report
Issuing Company Blueprint Medicines Corporation
Report Type Sustainability Report
Report Language EN
Report Filesize 7.9 MB
No. of Pages 17 pages
Reporting periodJanuary 1, 2020-December 31, 2020
Report Edition1
Assurance Provider Unknown
Reporting Standards SASB
Materiality Assessmenttrue